Narcan and Ursodiol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Narcan (naloxone hydrochloride) and Ursodiol (ursodiol). Common drug interactions include nasal congestion among females and blood calcium decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Narcan and Ursodiol. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Narcan?

Narcan has active ingredients of naloxone hydrochloride. eHealthMe is studying from 3,687 Narcan users. Check the latest studies of Narcan.

What is Ursodiol?

Ursodiol has active ingredients of ursodiol. It is often used in primary biliary cirrhosis. eHealthMe is studying from 19,061 Ursodiol users. Check the latest studies of Ursodiol.



On Jul, 17, 2026

44 people who take Narcan and Ursodiol together, and have interactions are studied.

Narcan and Ursodiol drug interactions.

What are the common drug interactions of Narcan and Ursodiol, by gender? *:

female:

  1. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  2. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  3. Neoplasm malignant (cancer tumour)
  4. Asthma
  5. Death
  6. Pain
  7. Urinary tract infection
  8. Nausea (feeling of having an urge to vomit)
  9. Uterine cancer
  10. Escherichia infection (bacterial infection by escherichia coli)

male:

  1. Blood calcium decreased
  2. Blood sodium decreased
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Hypoxia (low oxygen in tissues)
  5. Intestinal obstruction
  6. Multiple allergies (allergy to multiple agents)
  7. Neoplasm malignant (cancer tumour)
  8. Pancreatitis acute (sudden inflammation of pancreas)
  9. Pericardial effusion (fluid around the heart)
  10. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

What are the common drug interactions of Narcan and Ursodiol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  2. Infection
  3. Rash
  4. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  5. Chest pain
  6. Dyspnoea (difficult or laboured respiration)
  7. Headache (pain in head)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Neoplasm malignant (cancer tumour)
  10. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

30-39:

  1. Cystic fibrosis (disease of the secretary glands)
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Infection
  4. Pancreatitis acute (sudden inflammation of pancreas)

40-49:

  1. Blood calcium decreased
  2. Blood sodium decreased
  3. Blood urea increased
  4. Death
  5. Dysaesthesia (abnormal sensation)
  6. Dyskinesia (abnormality or impairment of voluntary movement)
  7. Enterococcus test positive
  8. Hypoxia (low oxygen in tissues)
  9. Intestinal obstruction
  10. Migraine (headache)

50-59:

  1. Angina pectoris (chest pain due to ischemia of the heart muscle)
  2. Bile output increased
  3. Pain
  4. Radiation injury (injuries are caused by radiation)

60+:

  1. Death
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Nausea (feeling of having an urge to vomit)
  4. Tremor (trembling or shaking movements in one or more parts of your body)
  5. Anticonvulsant drug level decreased
  6. Cardiac failure
  7. Confusional state
  8. Dizziness
  9. Dysphemia (stammering or stuttering)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Immunodeficiency Common Variable: 8 people, 18.18%
  2. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 9.09%
  3. Pain: 3 people, 6.82%
  4. Nausea And Vomiting: 3 people, 6.82%
  5. Nausea (feeling of having an urge to vomit): 3 people, 6.82%
  6. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Narcan and Ursodiol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Narcan and Ursodiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Narcan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ursodiol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Narcan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ursodiol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on naloxone hydrochloride and ursodiol (the active ingredients of Narcan and Ursodiol, respectively), and Narcan and Ursodiol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: